Director Shareholding

RNS Number : 0356O

Deltex Medical Group PLC

22 May 2015

 



22 May 2015

Deltex Medical Group plc

("the Company" or "Deltex Medical")

Director's holding

Julian Cazalet, non-executive director, has notified the Company that due to an administrative oversight in reporting, his beneficial holding of 1p ordinary shares in the Company is 189,314 greater than previously reported.

The additional shares were acquired on Mr Cazalet's behalf at a price of 11p per share in June 2014 as a consequence of managed funds of which Mr Cazalet is the beneficiary subscribing for shares in the Company's Open Offer. The subscription cost of these shares of £20,825 was in addition to the £50,000 that Mr Cazalet invested directly in acquiring 454,545 ordinary shares as part of the Placing in June 2014, as announced at the time.

After inclusion of the additional shares, Mr Cazalet is the beneficial owner of 4,872,123 ordinary shares of 1p each representing 2.27% of the Company's issued share capital.

For further information:

Deltex Medical Group plc	01243 774 837 [e-mail]
Nigel Keen, Chairman
Ewan Phillips, Chief Executive
Barry Curtis, Company Secretary
Nominated Adviser & Broker
Arden Partners plc	020 7614 5900
Chris Hardie
Joint Broker Zeus Capital Limited Phil Walker Dominic Wilson	020 7533 7727
Financial Public Relations
Newgate	020 7653 9850
Tim Thompson
Robyn McConnachie Ed Treadwell

 

END

 

 

RDSEANSAAFNSEEF